预先存在的心力衰竭,生物标志物概况和住院COVID-19患者的脆弱性:生物标志物驱动的风险框架
Ana-Maria Pah1, Maria-Laura Craciun1, Adina Avram2
1Cardiology Department, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romania.
Journal of clinical medicine
|March 14, 2026
概括
在COVID-19患者中,先前存在的心力衰竭 (HF) 表明心脏风险较高,但不能独立预测败血症或死亡率. 系统性炎症和心肌损伤标志物是COVID-19死亡率的关键预测因素.
科学领域:
- 心脏病学 心脏病学
- 传染性疾病 传染性疾病
- 关键护理医学 关键护理医学
背景情况:
- 心力衰竭 (HF) 与COVID-19患者的不良结果有关.
- 鉴于生物标志物,高射对败血症和死亡率的独立预测值仍然不清楚.
研究的目的:
- 为了确定先前存在的心力衰竭是否独立预测住院COVID-19患者的败血症和死亡率.
- 在调整炎症和心脏生物标志物后,评估HF与败血症和死亡率的关联.
主要方法:
- 对127名住院COVID-19患者进行了回顾性队列研究.
- 评估了先前存在的HF,基线生物标志物 (NT-proBNP,热素,CRP,IL-6) 和临床数据.
- 使用多变量逻辑回归来分析与败血症和死亡率的关联.
主要成果:
- 患有HF的患者表现出更高的心脏生物标志物和心血管并发症.
- 在HF和非HF组之间,败血症或死亡率没有显著差异.
- 在调整后,HF与败血症或死亡率没有独立相关.
- 升高的CRP,IL-6和高灵敏性热素独立地与死亡率相关.
结论:
- 在COVID-19患者中,先前存在的HF与心脏风险增加有关,但不是独立的败血症或死亡风险.
- 系统性炎症和急性心肌损伤标志物 (CRP,IL-6,热素) 是死亡率的主要驱动因素.
- 生物标志物驱动的风险分层对于COVID-19患者至关重要,特别是那些患有HF的人.
关键词:
在 COVID-19 疫情中,NT-proBNP 的国家统计数据.心脏生物标志物心脏生物标志物心脏衰竭是因为心脏衰竭.高灵敏度的托罗邦尼.炎症生物标志物 炎症生物标志物死亡率 死亡率这是一种血症.更多相关视频
04:05Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis
Published on: June 30, 2023
3.0K
08:51Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
2.2K
相关概念视频
01:30Heart Failure IV: Classification and Diagnostic Evaluation
520
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
520
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
684
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
684
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
1.1K
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.1K
01:30Acute Coronary Syndrome III: Diagnostic Studies
369
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
369
01:17Pathophysiology of Heart Failure
4.4K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.4K
01:29Heart Failure II: Pathophysiology
1.2K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.2K